RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$791M
AUM Growth
-$79M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1 +$15.7M
2 +$12.6M
3 +$12.1M
4
CAH icon
Cardinal Health
CAH
+$9.24M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$7.47M

Top Sells

1 +$19.8M
2 +$15.2M
3 +$14.9M
4
UNH icon
UnitedHealth
UNH
+$14.7M
5
MCK icon
McKesson
MCK
+$14.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLS icon
76
Apellis Pharmaceuticals
APLS
$3.76B
$1.61M 0.2%
93,250
+65,000
RLAY icon
77
Relay Therapeutics
RLAY
$1.27B
$1.59M 0.2%
460,000
BIIB icon
78
Biogen
BIIB
$22.1B
$1.51M 0.19%
12,000
-37,500
KURA icon
79
Kura Oncology
KURA
$958M
$1.44M 0.18%
250,000
+55,000
DNLI icon
80
Denali Therapeutics
DNLI
$2.37B
$1.4M 0.18%
100,000
XNCR icon
81
Xencor
XNCR
$1.02B
$1.3M 0.16%
165,750
-30,000
DOCS icon
82
Doximity
DOCS
$12.8B
$1.29M 0.16%
+21,000
JANX icon
83
Janux Therapeutics
JANX
$1.64B
$1.27M 0.16%
55,127
-86,500
ALKS icon
84
Alkermes
ALKS
$4.91B
$1.12M 0.14%
39,000
IOVA icon
85
Iovance Biotherapeutics
IOVA
$836M
$1.11M 0.14%
647,827
ANNX icon
86
Annexon
ANNX
$389M
$1.1M 0.14%
460,000
XENE icon
87
Xenon Pharmaceuticals
XENE
$3.23B
$1.1M 0.14%
35,000
IMCR icon
88
Immunocore
IMCR
$1.69B
$887K 0.11%
28,278
TECH icon
89
Bio-Techne
TECH
$10B
$772K 0.1%
+15,000
INMB icon
90
INmune Bio
INMB
$48.9M
$412K 0.05%
178,284
AMGN icon
91
Amgen
AMGN
$157B
-4,000
ARVN icon
92
Arvinas
ARVN
$708M
-183,000
AVTR icon
93
Avantor
AVTR
$10.3B
-47,826
BDX icon
94
Becton Dickinson
BDX
$53.6B
-19,000
BMY icon
95
Bristol-Myers Squibb
BMY
$88.3B
-325,000
ESPR icon
96
Esperion Therapeutics
ESPR
$672M
-1,066,495
GERN icon
97
Geron
GERN
$817M
-783,000
HUM icon
98
Humana
HUM
$35.2B
-46,830
ICLR icon
99
Icon
ICLR
$13.9B
-7,000
IDYA icon
100
IDEAYA Biosciences
IDYA
$2.84B
-39,500